Human trials set to begin within a year
Neuralink, the neurotechnology firm co-founded by Elon Musk, is preparing to begin human trials of a groundbreaking brain implant that could restore sight to the blind. Speaking at Y Combinator, Musk revealed that the company is targeting the next six to twelve months to test its first vision-related implants on human subjects.
“In the next six to 12 months, we’ll be doing our first implants for vision, where even if somebody is completely blind, we can write directly to the visual cortex,” Musk said.
Tested on animals, moving to humans
The device has already been tested on animals. According to Musk, a monkey has been living with the implant for three years. The initial version is expected to offer low-resolution vision, but Musk insists this will improve significantly over time.
“Long term, it’ll be very high resolution and you’ll be able to see multi-spectral wavelengths,” he added.
From blindness to ‘superhuman’ vision
Musk has previously made bold claims about the implant’s potential. In April, he stated that users’ vision would eventually “exceed the best human eyes.” Dubbed “Blindsight,” the implant could give users the ability to see ultraviolet, infrared, and even radar—ushering in what Musk described as a “superpower situation.”
Proven success with brain-computer interface
Neuralink has already demonstrated promising results with its brain-computer interface (BCI). In a high-profile case, Noland Arbaugh, a quadriplegic man, was able to control a computer using only his thoughts, thanks to the implant. Arbaugh’s case has served as a major milestone for the company, proving that the technology can be applied beyond theoretical models.
Challenges and expectations
While the technology is promising, Neuralink faces regulatory scrutiny and ethical concerns surrounding invasive neural procedures. The U.S. Food and Drug Administration granted Neuralink permission to begin human trials in 2023, and this upcoming study marks the company’s first step toward medical applications involving sensory restoration.
A future closer to science fiction
If successful, Neuralink’s vision implant could dramatically shift the landscape of medical technology and human capability. From restoring basic vision to unlocking new sensory perception, the company aims to redefine what it means to see.
Whether the technology lives up to Musk’s ambitious vision remains to be seen, but the upcoming trials could mark a major leap forward in neurotechnology.
